FDA

Does prenatal exposure to acetaminophen increase risk for ADHD?According to a study, a pregnant woman’s use of acetaminophen may be associated with increased risk of her child developing attention-deficit/hyperactivity disorder (ADHD). Plus: Another study says race is sole indicator of breast reconstruction likelihood. Also: FDA issues guidance on labeling for surgical aspirators.
FDA Assists Generic Drugmakers with New GuidancesThe FDA is promoting generic competition and issuing new REMS guidance.
FDA clears first opioid withdrawal deviceFDA granted a new indication to a device that can help reduce the symptoms of withdrawal from the prescription pain drugs.
How hospitals can cope with IV drug shortagesBecause of the impact of Hurricanes Maria and Irma on Puerto Rico’s infrastructure and drug manufacturing, hospitals face an ongoing shortage of IV fluids manufactured there.
Five approaches to effective cancer care managementManaging the care for members with cancer is unlike managing care for other chronic diseases. Here’s five ways to better care for cancer patients.
FDA approves first pill that can be tracked when ingestedFDA approved the first drug in the United States that has a digital ingestion tracking system, which records when the medication was taken.
Pharmacy Supply Lines Are Still Shaking After Storm Passes
Pharmacy Supply Lines Are Still Shaking After Storm PassesTwo hurricanes devastated the U.S. supply chain, affecting pharmacies all over—and leaving many to wonder what’s next.
FDA advisors recommend 2 opioid use disorder drugsTwo opioid use disorder drugs have been recommended for approval by FDA committees.
Midazolam Injections Recalled for Wrong Contents
Midazolam Injections Recalled for Wrong ContentsMidazolam syringes in blister packages contained syringes of Zofran.
The OD’s role with new diabetes drugsIt is important for eyecare providers to be familiar with these new drugs and findings. We often see patients with diabetes, metabolic syndrome, and high CV risk, and we are in a position to help counsel our patients about new treatments—and even suggest that appropriate patients have conversations with their primary-care physicians, endocrinologists and cardiologists.